ClariMedRecherchen nahtlos fortsetzen
30 Sek mit Email - kein Passwort, kein Formular. Ihr Verlauf bleibt auf jedem Gerät.
Verlauf
Keine Anfragen
HNO-Heilkunde-Leitlinien
ClariMed durchsucht HNO-Leitlinien von AWMF, DGHNO und internationalen Fachgesellschaften. Rhinosinusitis, Tinnitus, Pharyngitis, Hörsturz - quellenbasiert.
Jetzt kostenlos suchenEvidenzbasiert · Kostenlos · Ohne Anmeldung · DSGVO-konform
Typische Leitlinienfragen
Beispiele, wie sich dieses Fachgebiet in ClariMed durchsuchen lässt
“Chronische Rhinosinusitis - Therapie laut Leitlinie”
“Azithromycin bei Pharyngitis und Laryngitis”
“Mittelohrerguss - initiale Behandlungsoptionen vor HNO-Überweisung”
“Akuter Tinnitus - Diagnostik laut Leitlinie”
Jede Anfrage erhält eine evidenzbasierte Antwort mit direktem Link zur Originalleitlinie.
Probieren Sie es aus
Akute Rhinosinusitis - Therapie nach AWMF
HNO-Heilkunde-Leitlinien auf ClariMed
606 Leitlinien mit redaktioneller Zusammenfassung
AWMFNekrotisierende Enterokolitis (NEK)2026AWMFS2k-Leitlinie Konsultationsfassung: Einsatz von Exoskeletten im beruflichen Kontext zur Primär-, Sekundär- und Tertiärprävention von arbeitsassoziierten Muskel-Skelett-Erkrankungen oder -Beschwerden (S2k)AWMFS3-Leitlinie Tuberkuloseprävention bei neu zugewanderten Menschen (TB-Risk) (S3)2026BfArMICD-10-GM 2026 Kapitel VIII: Krankheiten des Ohres und des Warzenfortsatzes (H60-H95)BfArMICD-10-GM 2026 Kapitel XI: Krankheiten des Verdauungssystems (K00-K93)BfArMICD-10-GM 2026 Kapitel XXI: Faktoren, die den Gesundheitszustand beeinflussen und zur Inanspruchnahme des Gesundheitswesens führen (Z00-Z99)Cancer Council AustraliaClinical Practice Guidelines for Surveillance ColonoscopyCDCAbout the Prevention Effectiveness Fellowship2026CDCBotulism Prevention2026CDCFind a Screening Program Near You2026CDCNational Diabetes Prevention Program Infographic2026CDCNutrition Guidelines and Recommendations2026CDCPneumococcal Vaccination2026CDCUse of the GSK MenACWY-CRM/MenB-4C Pentavalent Meningococcal Vaccine Among Persons Aged ≥10 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, 20252026CochraneCochrane Review: Aminoglycosides, vancomycin, and metronidazole for people with cirrhosis and hepatic encephalopathyCochraneCochrane Review: Aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) for preventing colorectal cancer and colorectal adenoma in the general populationCochraneCochrane Review: Branched-chain amino acids for people with cirrhosis and hepatic encephalopathyCochraneCochrane Review: Enteral lipid supplements for the prevention and treatment of parenteral nutrition-associated liver disease in infantsCochraneCochrane Review: High-intensity interval training for reducing cardiometabolic syndrome in healthy but sedentary populationsCochraneCochrane Review: Lenacapavir as pre-exposure prophylaxis for HIV preventionCochraneCochrane Review: Liver and spleen stiffness as assessed by vibration-controlled transient elastography for diagnosing clinically significant portalCochraneCochrane Review: Total gastrectomy with splenectomy versus total gastrectomy with spleen preservation for gastric cancerDGVSDGVS: Colitis ulcerosa2026IQWiGIQWiG A25-117: Resmetirom (metabolische Dysfunktion-assoziierte Steatohepatitis) – Nutzenbewertung gemäß § 35a SGB V2026IQWiGIQWiG A26-08: Resmetirom (metabolische Dysfunktion-assoziierte Steatohepatitis) – Addendum zum Projekt A25-1172026IQWiGIQWiG S24-02: Überprüfung der unteren Altersgrenze und Frequenz der Früherkennungskoloskopie im Darmkrebs-Screeningprogramm2026IQWiGIQWiG V25-01: Evidenzrecherche zur S3-Leitlinie Allergische Rhinitis2026DGKKinderformularium: Adrenalin (Epinephrin) - Pädiatrische DosierungDGKKinderformularium: Vitamin D (Cholecalciferol) - Pädiatrische DosierungRKIRKI-Ratgeber: EHEC-ErkrankungSIGNSIGN: Risk estimation and the prevention of cardiovascular diseaseWHOPolicies and interventions to create healthy school food environments: WHO guideline2026ATSCare of Infants and Children with Tracheostomies: An Official American Thoracic Society Clinical Practice Guideline2025AWMFS3-Leitlinie Colitis ulcerosa v7.0 (AWMF 021-009, 2025)2025CochraneCochrane Review: Anti-IL-12/23p40 antibodies for induction of remission in Crohn's disease2025CochraneCochrane Review: Antibiotics for the common cold and acute purulent rhinitis2025CochraneCochrane Review: Aspartate aminotransferase-to-platelet ratio index (APRI) for staging of fibrosis in adults with chronic hepatitis C2025CochraneCochrane Review: Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis2025CochraneCochrane Review: Colchicine for the primary prevention of cardiovascular events2025CochraneCochrane Review: Colchicine for the secondary prevention of cardiovascular events2025CochraneCochrane Review: Dietary Approaches to Stop Hypertension (DASH) for the primary and secondary prevention of cardiovascular diseases2025CochraneCochrane Review: Effects of human papillomavirus (HPV) vaccination programmes on community rates of HPV-related disease and harms from vaccination2025CochraneCochrane Review: Evan's blue dye test for detection of aspiration in tracheostomized patients2025CochraneCochrane Review: Factors that influence caregivers' and adolescents' views and practices regarding human papillomavirus (HPV) vaccination for adolescents: a qualitative evidence synthesis2025CochraneCochrane Review: Human papillomavirus (HPV) vaccination for the prevention of cervical cancer and other HPV-related diseases: a network meta-analysis2025CochraneCochrane Review: Human stem cells for decompensated cirrhosis in adults2025CochraneCochrane Review: Influenza vaccination for healthcare workers who care for people aged 60 or older living in long-term care institutions2025CochraneCochrane Review: Intraperitoneal chemotherapy for gastric cancer2025CochraneCochrane Review: Linked color imaging versus conventional white-light colonoscopy for the detection of colorectal polyps2025CochraneCochrane Review: Postoperative nutritional support after pancreaticoduodenectomy in adults2025CochraneCochrane Review: Prognostic models for radiation-induced complications after radiotherapy in head and neck cancer patients2025CochraneCochrane Review: Prophylactic transarterial embolization in patients with bleeding peptic ulcers following endoscopic control of bleeding2025CochraneCochrane Review: Psychosocial interventions for smoking cessation in people with coronary heart disease2025CochraneCochrane Review: Silymarin for adults with metabolic dysfunction-associated steatotic liver disease2025CochraneCochrane Review: Stapler versus scalpel resection followed by handsewn closure of the pancreatic remnant for distal pancreatectomy2025CochraneCochrane Review: Surgical and endoscopic interventions in the management of idiopathic achalasia2025DGIMDGIM Klug entscheiden: Gastroenterologie (19 Empfehlungen)2025DGVSDGVS: Qualitätsanforderungen in der gastrointestinalen Endoskopie2025Diabetes CanadaDiabetes Canada Chapter 42: Diabetes and Metabolic Dysfunction-associated Steatotic Liver Disease in Adults (2025)European Society for the Study of Coeliac DiseaseEuropean Society for the Study of Coeliac Disease 2025 Updated Guidelines on the Diagnosis and Management of Coeliac Disease in Adults. Part 1: Diagnostic Approach2025G-BAG-BA Nutzenbewertung: Guselkumab (Neues Anwendungsgebiet: Colitis ulcerosa, vorbehandelt)2025G-BAG-BA Nutzenbewertung: Guselkumab (Neues Anwendungsgebiet: Morbus Crohn, vorbehandelt)2025G-BAG-BA Nutzenbewertung: Mirikizumab (Neues Anwendungsgebiet: Morbus Crohn, vorbehandelt)2025G-BAG-BA Nutzenbewertung: Natriumthiosulfat (Bekannter Wirkstoff mit neuem Unterlagenschutz: Vorbeugung von Ototoxizität durch Cisplatin-Chemotherapie, solide Tumoren, 1 Monat bis < 18 Jahre)2025G-BAG-BA Nutzenbewertung: Nirsevimab (Erstmalige Dossierpflicht: Prävention von RSV-Infektionen, Kinder während ihrer 1. RSV-Saison, die nicht im Therapiehinweis zu RSV-Antikörpern adressiert sind)2025G-BAG-BA Nutzenbewertung: Nivolumab (Neues Anwendungsgebiet: Kolorektalkarzinom mit MSI-H oder mit dMMR, Erstlinie, Kombination mit Ipilimumab)2025G-BAG-BA Nutzenbewertung: Resmetirom (metabolische Dysfunktion-assoziierte Steatohepatitis (MASH), nicht-zirrhotisch)2025G-BAG-BA Nutzenbewertung: Seladelpar (primär biliäre Cholangitis (Kombination mit Ursodeoxycholsäure))2025G-BAG-BA Nutzenbewertung: Tislelizumab (Neues Anwendungsgebiet: Adenokarzinom des Magens oder des gastroösophagealen Übergangs, PD-L1-Expression ≥ 52025G-BAG-BA Nutzenbewertung: Tislelizumab (Neues Anwendungsgebiet: Plattenepithelkarzinom des Ösophagus, PD-L1-Expression TAP-Score ≥ 5 %, Erstlinie, Kombination mit platinbasierter Chemotherapie)2025G-BAG-BA Nutzenbewertung: Tislelizumab (Neues Anwendungsgebiet: rezidiviertes oder metastasiertes Nasopharynxkarzinom (NPC), Erstlinie, Kombination mit Gemcitabin and Cisplatin)2025G-BAG-BA Nutzenbewertung: Tislelizumab (Plattenepithelkarzinom des Ösophagus, nach Vortherapie)2025G-BAG-BA Nutzenbewertung: Trastuzumab deruxtecan (Neue wissenschaftliche Erkenntnisse § 14: Adenokarzinom des Magens oder des gastroösophagealen Übergangs, HER2+, nach Trastuzumab-basierter Therapie)2025IQWiGIQWiG A24-117: Dupilumab (eosinophile Ösophagitis, 1 bis 11 Jahre) – Nutzenbewertung gemäß § 35a SGB V2025IQWiGIQWiG A25-131: Guselkumab (Morbus Crohn) - Addendum zum Projekt A25-752025IQWiGIQWiG A25-132: Guselkumab (Colitis ulcerosa) – Addendum zum Projekt A25-742025IQWiGIQWiG A25-42 : Mirikizumab (Morbus Crohn) – Nutzenbewertung gemäß § 35a SGB V2025IQWiGIQWiG A25-74: Guselkumab (Colitis ulcerosa) – Nutzenbewertung gemäß § 35a SGB V2025IQWiGIQWiG A25-75: Guselkumab (Morbus Crohn) – Nutzenbewertung gemäß § 35a SGB V2025IQWiGIQWiG A25-99: Mirikizumab (Morbus Crohn) - Addendum zum Projekt A25-422025IQWiGIQWiG G24-30: Elafibranor (primäre biliäre Cholangitis) – Bewertung gemäß § 35a Abs. 1 Satz 11 SGB V2025IQWiGIQWiG G25-13: Seladelpar (primär biliären Cholangitis [PBC]) – Bewertung gemäß § 35a Abs. 1 Satz 11 SGB V2025IQWiGIQWiG P24-03: Gesundheitsinformation zu Möglichkeiten der Tabakentwöhnung2025Leitlinienprogramm OnkologieS3-Leitlinie Magenkarzinom v3.1 (2025)2025USPSTFPrimary Care Behavioral Counseling Interventions to Support Breastfeeding: US Preventive Services Task Force Recommendation Statement.2025USPSTFScreening for Food Insecurity: US Preventive Services Task Force Recommendation Statement.2025USPSTFScreening for Intimate Partner Violence and Caregiver Abuse of Older or Vulnerable Adults: US Preventive Services Task Force Recommendation Statement.2025USPSTFScreening for Osteoporosis to Prevent Fractures: US Preventive Services Task Force Recommendation Statement.2025USPSTFScreening for Syphilis Infection During Pregnancy: US Preventive Services Task Force Reaffirmation Recommendation Statement.2025WHOBehavioural and social drivers of influenza vaccination: tools and practical guidance for achieving high uptake2025WHOFasciola: background document for the WHO guidelines for drinking-water quality and the WHO guidelines on sanitation and health2025WHOFramework to implement a life course approach in practice2025WHOGlobal guidance on monitoring public health and social measures policies during health emergencies, rev. ed., 2025.2025WHOGuidelines on hand hygiene in community settings2025WHOInternational travel and health: module 4: vaccine-preventable diseases and vaccines2025WHORESPECT women: preventing violence against women, 2nd ed.2025WHOSocial and behaviour change interventions for contraception and family planning2025WHOStrategic actions for infection prevention and control and water, sanitation and hygiene during mpox outbreak response: executive summary2025WHOUse of lower-sodium salt substitutes: WHO guideline 2025WHOWHO guideline on fortification of edible oils and fats with vitamins A and D for public health2025ACGACG Clinical Guideline: Diagnosis and Management of Gallstones2024AkdÄAkdÄ: Rote-Hand-Brief zu Alofisel (Darvadstrocel): Rücknahme vom EU-Markt, da der klinische Nutzen nicht mehr nachgewiesen ist, um seine weitere2024ATSManagement of Persistent, Post-adenotonsillectomy Obstructive Sleep Apnea in Children: An Official American Thoracic Society Clinical Practice Guideline2024CDCCDC Hepatitis B Vaccination Guidelines2024CDCCDC Hepatitis C Testing and Management2024CDCCDC Parasitic Diseases Treatment Guidelines2024CochraneCochrane Review: Conservative, physical and surgical interventions for managing faecal incontinence and constipation in adults with central neurological diseases2024CochraneCochrane Review: Endoscopic sphincterotomy for adults with biliary sphincter of Oddi dysfunction2024CochraneCochrane Review: Infliximab for maintenance of medically-induced remission in Crohn's disease2024CochraneCochrane Review: Meditation for the primary and secondary prevention of cardiovascular disease2024CochraneCochrane Review: Mobile phone text messaging for medication adherence in secondary prevention of cardiovascular disease2024CochraneCochrane Review: Molecular biomarkers for predicting complete response to preoperative chemoradiation in people with locally advanced rectal cancer2024CochraneCochrane Review: Prebiotics for induction and maintenance of remission in ulcerative colitis2024CochraneCochrane Review: Shared decision-making for supporting women's decisions about breast cancer screening2024CochraneCochrane Review: Standard- versus extended-duration anticoagulation for primary venous thromboembolism prophylaxis in acutely ill medical patients2024CochraneCochrane Review: Transjugular intrahepatic portosystemic shunts for adults with hepatorenal syndrome2024CochraneCochrane Review: Uncut Roux-en-Y reconstruction after distal gastrectomy for gastric cancer2024CochraneCochrane Review: Vitamin E for people with non-alcoholic fatty liver disease2024DGVSDGVS: Hepatozelluläres Karzinom und biliäre Karzinome2024DGVSDGVS: Morbus Crohn2024G-BAG-BA Nutzenbewertung: Elafibranor (primär biliäre Cholangitis (Kombination mit Ursodeoxycholsäure))2024G-BAG-BA Nutzenbewertung: Etrasimod (Colitis ulcerosa, ≥ 16 Jahre)2024G-BAG-BA Nutzenbewertung: Fruquintinib (Kolorektalkarzinom, vorbehandelte Patienten)2024G-BAG-BA Nutzenbewertung: Futibatinib (Cholangiokarzinom, mit FGFR2-Fusion oder FGFR2-Rearrangement, nach mind. 1 Vortherapie)2024G-BAG-BA Nutzenbewertung: Maralixibat (Neues Anwendungsgebiet: progressive familiäre intrahepatische Cholestase (PFIC), ≥ 3 Monate)2024G-BAG-BA Nutzenbewertung: Nirsevimab (Neues Anwendungsgebiet: Sekundärprophylaxe von RSV-Infektionen, Kinder während ihrer 2. RSV-Saison , ≤ 24 Lebensmonate)2024G-BAG-BA Nutzenbewertung: Pembrolizumab (Neues Anwendungsgebiet: Biliäre Tumore, Erstlinie, Kombination mit Gemcitabin und Cisplatin)2024G-BAG-BA Nutzenbewertung: Risankizumab (Neues Anwendungsgebiet: Colitis ulcerosa, vorbehandelt)2024G-BAG-BA Nutzenbewertung: Zolbetuximab (Adenokarzinom des Magens oder des gastroösophagealen Übergangs, HER2-negativ, Erstlinie, Kombination mit fluoropyrimidin- und platinhaltiger Chemotherapie)2024IQWiGIQWiG A24-42: Etrasimod (Colitis ulcerosa) – Nutzenbewertung gemäß § 35a SGB V2024IQWiGIQWiG A24-84: Risankizumab (Colitis ulcerosa) – Nutzenbewertung gemäß § 35a SGB V2024Leitlinienprogramm OnkologieS3-Leitlinie Hepatozelluläres Karzinom und biliäre Karzinome v5.2 (2024)2024Leitlinienprogramm OnkologieS3-Leitlinie Lungenkarzinom v2.2 (2024)2024Leitlinienprogramm OnkologieS3-Leitlinie Ösophaguskarzinom v4.0 (2024)2024Leitlinienprogramm OnkologieS3-Leitlinie Prävention von Hautkrebs v2.1 (2024)2024RACGPGuidelines for preventive activities in general practice (Red Book)2024RACGPNational Guide to preventive healthcare for Aboriginal and Torres Strait Islander people2024RACGPPutting prevention into practice: Guidelines for the implementation of prevention in the general practice setting2024RACGPSmoking, nutrition, alcohol, physical activity (SNAP)2024USPSTFInterventions for High Body Mass Index in Children and Adolescents: US Preventive Services Task Force Recommendation Statement.2024USPSTFInterventions to Prevent Falls in Community-Dwelling Older Adults: US Preventive Services Task Force Recommendation Statement.2024USPSTFPrimary Care Interventions to Prevent Child Maltreatment: US Preventive Services Task Force Recommendation Statement.2024USPSTFScreening and Supplementation for Iron Deficiency and Iron Deficiency Anemia During Pregnancy: US Preventive Services Task Force Recommendation Statement.2024USPSTFScreening for Breast Cancer: US Preventive Services Task Force Recommendation Statement.2024USPSTFScreening for Speech and Language Delay and Disorders in Children: US Preventive Services Task Force Recommendation Statement.2024WHOBuilding health system resilience to public health challenges: guidance for implementation in countries2024WHODevelopment of WHO immunization policy and strategic guidance2024WHOFiscal policies to promote healthy diets: WHO guideline2024WHOGuidance on global monitoring for diabetes prevention and control: Framework, indicators and application2024WHOGuidelines for drinking-water quality: small water supplies2024WHOImplementation of self-care interventions for health and well-being: guidance for health systems2024WHOImproving the health and wellbeing of children and adolescents: guidance on scheduled child and adolescent well-care visits2024WHORecommendations for the treatment of Trichomonas vaginalis, Mycoplasma genitalium, Candida albicans, bacterial vaginosis and human papillomavirus (anogenital warts)2024WHOSupporting member states in reaching informed decision-making on engaging with private sector entities for the prevention and control of noncommunicable diseases: a practical tool2024WHOTarget setting for low carbon
sustainable health systems2024WHOWater, sanitation and hygiene and infection prevention and control measures for infectious diarrhoea in health-care settings: operational guide2024WHOWHO Guidelines on Hepatitis B and C Testing2024WHOWHO South-East Asia Region Sodium Benchmarks for Packaged Foods2024ACGACG: Celiac Disease Diagnosis2023AkdÄAkdÄ: Rote-Hand-Brief zu Simponi® (Golimumab) 50 mg und 100 mg: Wichtige Änderungen in der Injektionsanleitung für den vorgefüllten Injektor2023AWMFGastroösophageale Refluxkrankheit und eosinophile Ösophagitis2023AWMFLebertransplantation2023BfArMFäkale Mikrobiota-Transplantation (FMT, Stuhltransplantation): Risiko für die Übertragung von multiresistenten Erregern2023CochraneCochrane Review: Antibiotics for acute otitis media in children2023CochraneCochrane Review: Environmental interventions for preventing falls in older people living in the community2023CochraneCochrane Review: Factors that impact on recruitment to vaccine trials in the context of a pandemic or epidemic: a qualitative evidence synthesis2023CochraneCochrane Review: Granulocyte colony-stimulating factor with or without stem or progenitor cell or growth factors infusion for people with compensated or decompensated advanced chronic liver disease2023CochraneCochrane Review: Head impulse, nystagmus, and test of skew examination for diagnosing central causes of acute vestibular syndrome2023CochraneCochrane Review: Interventions for improving health literacy in migrants2023CochraneCochrane Review: Interventions for the treatment of oral cavity and oropharyngeal cancers: surgical treatment2023CochraneCochrane Review: Intratympanic gentamicin for Ménière's disease2023CochraneCochrane Review: Lifestyle and dietary interventions for Ménière's disease2023CochraneCochrane Review: Medical treatment of eosinophilic esophagitis2023CochraneCochrane Review: Non-pharmacological interventions for prophylaxis of vestibular migraine2023CochraneCochrane Review: Patient education interventions for the management of inflammatory bowel disease2023CochraneCochrane Review: Pharmacological interventions for acute attacks of vestibular migraine2023CochraneCochrane Review: Pharmacological interventions for prophylaxis of vestibular migraine2023CochraneCochrane Review: Pharmacological treatment of gastro-oesophageal reflux in children2023CochraneCochrane Review: Positive pressure therapy for Ménière's disease2023CochraneCochrane Review: Preoperative combined mechanical and oral antibiotic bowel preparation for preventing complications in elective colorectal surgery2023CochraneCochrane Review: Primary-level and community worker interventions for the prevention of mental disorders and the promotion of well-being in low- and middle-income countries2023CochraneCochrane Review: Probiotics for management of functional abdominal pain disorders in children2023CochraneCochrane Review: Re-feeding versus discarding gastric residuals to improve growth in preterm infants2023CochraneCochrane Review: Remote care through telehealth for people with inflammatory bowel disease2023CochraneCochrane Review: Rifaximin for prevention and treatment of hepatic encephalopathy in people with cirrhosis2023CochraneCochrane Review: Routine monitoring of gastric residual for prevention of necrotising enterocolitis in preterm infants2023CochraneCochrane Review: Surgery for nasal polyposis in cystic fibrosis2023CochraneCochrane Review: Systemic pharmacological interventions for Ménière's disease2023CochraneCochrane Review: Vedolizumab for induction and maintenance of remission in Crohn's disease2023CochraneCochrane Review: Ventilation tubes (grommets) for otitis media with effusion (OME) in children2023G-BAG-BA Nutzenbewertung: Dupilumab (Neues Anwendungsgebiet: Eosinophile Ösophagitis, ≥ 12 Jahre, mind. 40 kg)2023G-BAG-BA Nutzenbewertung: Durvalumab (Neues Anwendungsgebiet: Biliäre Tumore, Erstlinie, Kombination mit Gemcitabin und Cisplatin)2023G-BAG-BA Nutzenbewertung: Ivosidenib (Cholangiokarzinom mit IDH1-R132-Mutation, nach mind. 1 Vortherapie)2023G-BAG-BA Nutzenbewertung: Mirikizumab (Colitis Ulcerosa, vorbehandelt)2023G-BAG-BA Nutzenbewertung: Trastuzumab deruxtecan (Neues Anwendungsgebiet: Adenokarzinom des Magens oder des gastroösophagealen Übergangs, HER2-positiv, nach Trastuzumab-basierter Therapie)2023G-BAG-BA Nutzenbewertung: Trifluridin/Tipiracil (Neues Anwendungsgebiet: Kolorektalkarzinom, nach 2 Vortherapien, Kombination mit Bevacizumab)2023G-BAG-BA Nutzenbewertung: Upadacitinib (Neues Anwendungsgebiet: Morbus Crohn, vorbehandelt)2023IQWiGIQWiG A22-133: Risankizumab (Morbus Crohn) - Nutzenbewertung gemäß § 35a SGB V2023IQWiGIQWiG A23-38: Upadacitinib (Morbus Crohn) – Nutzenbewertung gemäß § 35a SGB V2023IQWiGIQWiG A23-40: Risankizumab (Morbus Crohn) – Addendum zum Auftrag A22-1332023IQWiGIQWiG A23-73: Mirikizumab (Colitis Ulcerosa) - Nutzenbewertung gemäß § 35a SGB V2023IQWiGIQWiG G23-02: Maralixibat (cholestatischer Pruritus) – Bewertung gemäß § 35a Abs. 1 Satz 11 SGB V2023IQWiGIQWiG GA19-03: Gesundheitsinformationen für schwer erreichbare Zielgruppen: eine qualitative Bedarfsanalyse2023IQWiGIQWiG P21-04A : Evaluation von Einladungsschreiben und Versicherteninformation zum Darmkrebs-Screening2023IQWiGIQWiG P22-01: Entscheidungshilfe Gallenblasenentfernung2023IQWiGIQWiG V23-01: Evidenzrecherche zur S3-Leitlinie Beratung zur Vitamin D Substitution2023USPSTFPreexposure Prophylaxis to Prevent Acquisition of HIV: US Preventive Services Task Force Recommendation Statement.2023USPSTFScreening and Preventive Interventions for Oral Health in Adults: US Preventive Services Task Force Recommendation Statement.2023USPSTFScreening and Preventive Interventions for Oral Health in Children and Adolescents Aged 5 to 17 Years: US Preventive Services Task Force Recommendation Statement.2023USPSTFScreening for Anxiety Disorders in Adults: US Preventive Services Task Force Recommendation Statement.2023USPSTFScreening for Depression and Suicide Risk in Adults: US Preventive Services Task Force Recommendation Statement.2023USPSTFScreening for Hypertensive Disorders of Pregnancy: US Preventive Services Task Force Final Recommendation Statement.2023USPSTFScreening for Latent Tuberculosis Infection in Adults: US Preventive Services Task Force Recommendation Statement.2023USPSTFScreening for Lipid Disorders in Children and Adolescents: US Preventive Services Task Force Recommendation Statement.2023USPSTFScreening for Skin Cancer: US Preventive Services Task Force Recommendation Statement.2023USPSTFSerologic Screening for Genital Herpes Infection: US Preventive Services Task Force Reaffirmation Recommendation Statement.2023WHOA guide to implementing the One Health Joint Plan of Action at national level2023WHOCarbohydrate intake for adults and children: WHO guideline2023WHOCity-level monitoring guidance for the prevention and control of noncommunicable diseases and injuries2023WHOGlobal Accelerated Action for the Health of Adolescents (AA-HA!) - Second edition2023WHOGuidance on development and implementation of a national deployment and vaccination plan for vaccines against pandemic influenza and other respiratory viruses of pandemic potential2023WHOPacific physical activity and sedentary behaviour guidelines for everyone2023WHOPolicies to protect children from the harmful impact of food marketing: WHO guideline2023WHOPublic health pesticide management: a course module2023WHOSaturated fatty acid and trans-fatty acid intake for adults and children: WHO guideline2023WHOSelf-care interventions: human papillomavirus (HPV) self-sampling as part of cervical cancer screening and treatment, 2022 update2023WHOSurveillance Guide for Vaccine-Preventable Diseases in the WHO South-East Asia Region (Strategic guidance on VPD surveillance in the WHO South-East Asia Region)2023WHOTotal fat intake for the prevention of unhealthy weight gain in adults and children: WHO guideline2023WHOUse of non-sugar sweeteners: WHO guideline2023WHOVaccinating older adults against COVID-192023ACGACG Clinical Guideline: Diagnosis and Management of GERD2022AkdÄAkdÄ: „UAW-News International“: Cholezystitis im Zusammenhang mit DPP-4-Inhibitoren (Gliptine)2022AkdÄAkdÄ: Rote-Hand-Brief zu Ocaliva® (Obeticholsäure): Neue2022AWMFNicht-alkoholische Fettlebererkrankungen2022AWMFS2k-Leitlinie Zöliakie (AWMF 021-021, 2022)2022CochraneCochrane Review: Antibiotics for uncomplicated diverticulitis2022CochraneCochrane Review: Coriolus (Trametes) versicolor mushroom to reduce adverse effects from chemotherapy or radiotherapy in people with colorectal cancer2022CochraneCochrane Review: Duct-to-mucosa versus other types of pancreaticojejunostomy for the prevention of postoperative pancreatic fistula following pancreaticoduodenectomy2022CochraneCochrane Review: Effects of a gluten-reduced or gluten-free diet for the primary prevention of cardiovascular disease2022CochraneCochrane Review: Electromagnetic-guided versus endoscopic-guided postpyloric placement of nasoenteral feeding tubes2022CochraneCochrane Review: Fundoplication in laparoscopic Heller's cardiomyotomy for achalasia2022CochraneCochrane Review: Ginkgo biloba for tinnitus2022CochraneCochrane Review: Guaiac-based faecal occult blood tests versus faecal immunochemical tests for colorectal cancer screening in average-risk individuals2022CochraneCochrane Review: Guidewire-assisted cannulation of the common bile duct for the prevention of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis2022CochraneCochrane Review: Interventions to increase COVID-19 vaccine uptake: a scoping review2022CochraneCochrane Review: Intratympanic corticosteroids for sudden sensorineural hearing loss2022CochraneCochrane Review: Medical interventions for chronic rhinosinusitis in cystic fibrosis2022CochraneCochrane Review: Mu-opioid antagonists for opioid-induced bowel dysfunction in people with cancer and people receiving palliative care2022CochraneCochrane Review: Physical activity for treatment of irritable bowel syndrome2022CochraneCochrane Review: Preprocedural mouth rinses for preventing transmission of infectious diseases through aerosols in dental healthcare providers2022CochraneCochrane Review: Probiotics for preventing acute upper respiratory tract infections2022CochraneCochrane Review: Probiotics for the prevention of Hirschsprung-associated enterocolitis2022CochraneCochrane Review: Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleeding2022CochraneCochrane Review: Smoking cessation for secondary prevention of cardiovascular disease2022CochraneCochrane Review: Stem cell transplantation for induction of remission in medically refractory Crohn's disease2022CochraneCochrane Review: Synbiotics to prevent necrotising enterocolitis in very preterm or very low birth weight infants2022CochraneCochrane Review: Synbiotics, prebiotics and probiotics for solid organ transplant recipients2022CochraneCochrane Review: Tacrolimus (FK506) for induction of remission in corticosteroid-refractory ulcerative colitis2022CochraneCochrane Review: The combination of transcatheter arterial chemoembolisation (TACE) and thermal ablation versus TACE alone for hepatocellular carcinoma2022CochraneCochrane Review: Unconditional cash transfers for reducing poverty and vulnerabilities: effect on use of health services and health outcomes in low- and middle-income countries2022CochraneCochrane Review: Unintended consequences of measures implemented in the school setting to contain the COVID-19 pandemic: a scoping review2022CochraneCochrane Review: Workplace interventions to reduce the risk of SARS-CoV-2 infection outside of healthcare settings2022DGVSDGVS: Chronische Obstipation2022G-BAG-BA Nutzenbewertung: Eravacyclin (Reserveantibiotikum: Komplizierte intraabdominale Infektionen (cIAI))2022G-BAG-BA Nutzenbewertung: Nivolumab (Neues Anwendungsgebiet: Plattenepithelkarzinom des Ösophagus, PD-L1-Expression ≥ 1, Erstlinie, Kombination mit Ipilimumab)2022G-BAG-BA Nutzenbewertung: Olopatadin/Mometason (allergische Rhinitis, ≥ 12 Jahre)2022G-BAG-BA Nutzenbewertung: Pembrolizumab (Neues Anwendungsgebiet: Dünndarmkarzinom mit MSI-H oder dMMR, vorbehandelt)2022G-BAG-BA Nutzenbewertung: Pembrolizumab (Neues Anwendungsgebiet: Kolorektalkarzinom mit MSI-H oder mit dMMR, nach Fluoropyrimidin-basierter Kombinationstherapie)2022G-BAG-BA Nutzenbewertung: Pembrolizumab (Neues Anwendungsgebiet: Magenkarzinom mit MSI-H oder dMMR, vorbehandelt)2022G-BAG-BA Nutzenbewertung: Ripretinib (Gastrointestinale Stromatumoren (GIST), ≥ 3 Vortherapien)2022G-BAG-BA Nutzenbewertung: Upadacitinib (Neues Anwendungsgebiet: Colitis ulcerosa, vorbehandelt)2022G-BAG-BA Nutzenbewertung: Vedolizumab (Neues Anwendungsgebiet: Antibiotika-refraktäre Pouchitis, vorbehandelte Patienten)2022IQWiGIQWiG A21-155: Filgotinib (Colitis ulcerosa) - Nutzenbewertung gemäß § 35a SGB V2022IQWiGIQWiG A21-166: Ozanimod (Colitis Ulcerosa) - Nutzenbewertung gemäß § 35a SGB V2022IQWiGIQWiG A22-42: Mepolizumab (chronische Rhinosinusitis mit Nasenpolypen) - Addendum zum Auftrag A21-1502022IQWiGIQWiG A22-91: Upadacitinib (Colitis ulcerosa) – Nutzenbewertung gemäß § 35a SGB V2022USPSTFAspirin Use to Prevent Cardiovascular Disease: US Preventive Services Task Force Recommendation Statement.2022USPSTFBehavioral Counseling Interventions to Promote a Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without2022USPSTFHormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Persons: US Preventive Services Task Force Recommendation Statement.2022USPSTFScreening for Anxiety in Children and Adolescents: US Preventive Services Task Force Recommendation Statement.2022USPSTFScreening for Atrial Fibrillation: US Preventive Services Task Force Recommendation Statement.2022USPSTFScreening for Chronic Obstructive Pulmonary Disease: US Preventive Services Task Force Reaffirmation Recommendation Statement.2022USPSTFScreening for Depression and Suicide Risk in Children and Adolescents: US Preventive Services Task Force Recommendation Statement.2022USPSTFScreening for Eating Disorders in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement.2022USPSTFScreening for Impaired Visual Acuity in Older Adults: US Preventive Services Task Force Recommendation Statement.2022USPSTFScreening for Obstructive Sleep Apnea in Adults: US Preventive Services Task Force Recommendation Statement.2022USPSTFScreening for Prediabetes and Type 2 Diabetes in Children and Adolescents: US Preventive Services Task Force Recommendation Statement.2022USPSTFScreening for Primary Open-Angle Glaucoma: US Preventive Services Task Force Recommendation Statement.2022USPSTFStatin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement.2022USPSTFVitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: US Preventive Services Task Force Recommendation Statement.2022WHOA short guide to cancer screening: increase effectiveness, maximize benefits and minimize harm2022WHOCaring for those who care: Guide for the development and implementation of occupational health and safety programmes for health workers2022WHOGuidelines on long-acting injectable cabotegravir for HIV prevention2022WHOHealth systems resilience toolkit: a WHO global public health good to support building and strengthening of sustainable health systems resilience in countries with various contexts2022WHOImplementation guide for vaccination of health workers2022WHOMicroplanning manual to
guide implementation of
preventive chemotherapy
to control and eliminate
neglected tropical diseases2022WHOOptimizing brain health across the life course: WHO position paper2022WHOWHO preferred
product
characteristics
for monoclonal
antibodies for
HIV prevention2022ACGACG: Colorectal Cancer Screening2021ACGACG: Irritable Bowel Syndrome2021AkdÄAkdÄ: Rote-Hand-Brief zu ▼ Xeljanz® (Tofacitinib): Erhöhtes2021AWMFAWMF 021-020: S3-Leitlinie Divertikelkrankheit / Divertikulitis2021CochraneCochrane Review: Antibiotics for treatment of sore throat in children and adults2021CochraneCochrane Review: Antidepressants for functional abdominal pain disorders in children and adolescents2021CochraneCochrane Review: Band ligation versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis2021CochraneCochrane Review: Beta-blockers versus placebo or no intervention for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis2021CochraneCochrane Review: Biologics for chronic rhinosinusitis2021CochraneCochrane Review: Clinical assessment for the detection of oral cavity cancer and potentially malignant disorders in apparently healthy adults2021CochraneCochrane Review: Compression stockings for preventing deep vein thrombosis in airline passengers2021CochraneCochrane Review: Day care as a strategy for drowning prevention in children under 6 years of age in low- and middle-income countries2021CochraneCochrane Review: Diagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesions2021CochraneCochrane Review: Drug therapies for reducing gastric acidity in people with cystic fibrosis2021CochraneCochrane Review: Education and training for preventing sharps injuries and splash exposures in healthcare workers2021CochraneCochrane Review: Humidification of indoor air for preventing or reducing dryness symptoms or upper respiratory infections in educational settings and at the workplace2021CochraneCochrane Review: Intermittent fasting for the prevention of cardiovascular disease2021CochraneCochrane Review: International travel-related control measures to contain the COVID-19 pandemic: a rapid review2021CochraneCochrane Review: Interventions for preventing distal intestinal obstruction syndrome (DIOS) in cystic fibrosis2021CochraneCochrane Review: Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease2021CochraneCochrane Review: Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction2021CochraneCochrane Review: Interventions for the treatment of persistent post-COVID-19 olfactory dysfunction2021CochraneCochrane Review: Interventions for treating distal intestinal obstruction syndrome (DIOS) in cystic fibrosis2021CochraneCochrane Review: Interventions in outside-school hours childcare settings for promoting physical activity amongst schoolchildren aged 4 to 12 years2021CochraneCochrane Review: Lifestyle modifications for nonalcohol-related fatty liver disease: a network meta-analysis2021CochraneCochrane Review: Making wise choices about low-value health care in the COVID-19 pandemic2021CochraneCochrane Review: Mobile phone-based interventions for improving adherence to medication prescribed for the primary prevention of cardiovascular disease in adults2021CochraneCochrane Review: Non-pharmacological measures implemented in the setting of long-term care facilities to prevent SARS-CoV-2 infections and their consequences: a rapid review2021CochraneCochrane Review: Patient and lay carer education for preventing pressure ulceration in at-risk populations2021CochraneCochrane Review: Postoperative adjuvant chemotherapy for resectable cholangiocarcinoma2021CochraneCochrane Review: Prevention of depression in adults with long-term physical conditions2021CochraneCochrane Review: Primary prevention of variceal bleeding in people with oesophageal varices due to liver cirrhosis: a network meta-analysis2021CochraneCochrane Review: Prophylactic abdominal drainage for pancreatic surgery2021CochraneCochrane Review: Roux-en-Y versus Billroth-I reconstruction after distal gastrectomy for gastric cancer2021CochraneCochrane Review: Secondary prevention of variceal bleeding in adults with previous oesophageal variceal bleeding due to decompensated liver cirrhosis: a network meta-analysis2021CochraneCochrane Review: Smoking cessation for improving mental health2021CochraneCochrane Review: Surgical interventions for the early management of Bell's palsy2021CochraneCochrane Review: Systemic antibiotics for chronic suppurative otitis media2021CochraneCochrane Review: Timing of pancreatic enzyme replacement therapy (PERT) in cystic fibrosis2021CochraneCochrane Review: Treatment for bleeding oesophageal varices in people with decompensated liver cirrhosis: a network meta-analysis2021CochraneCochrane Review: Walking for hypertension2021DGVSDGVS: Intestinale Motilitätsstörungen2021DGVSDGVS: Pankreatitis2021DGVSDGVS: Reizdarmsyndrom2021G-BAG-BA Nutzenbewertung: Filgotinib (Neues Anwendungsgebiet: Colitis Ulcerosa)2021G-BAG-BA Nutzenbewertung: Mepolizumab (Neues Anwendungsgebiet: Chronische Rhinosinusitis mit Nasenpolypen)2021G-BAG-BA Nutzenbewertung: Nivolumab (Neues Anwendungsgebiet: Adenokarzinom des Magens, des gastroösophagealen Übergangs oder des Ösophagus, CPS ≥ 52021G-BAG-BA Nutzenbewertung: Nivolumab (Neues Anwendungsgebiet: Kolorektalkarzinom mit Mismatch-Reparatur-Defizienz oder hoher Mikrosatelliteninstabilität2021G-BAG-BA Nutzenbewertung: Nivolumab (Neues Anwendungsgebiet: Plattenepithelkarzinom des Ösophagus, vorbehandelte Patienten)2021G-BAG-BA Nutzenbewertung: Odevixibat (Cholestase (≥ 6 Monate))2021G-BAG-BA Nutzenbewertung: Ozanimod (Neues Anwendungsgebiet: Colitis Ulcerosa, vorbehandelte Patienten)2021G-BAG-BA Nutzenbewertung: Pembrolizumab (Neues Anwendungsgebiet: Kolorektalkarzinom mit MSI-H oder dMMR, Erstlinie)2021G-BAG-BA Nutzenbewertung: Pemigatinib (Cholangiokarzinom mit FGFR2-Fusion oder FGFR2-Rearrangement, nach mind. 1 Vortherapie)2021IDSAIDSA: Clostridioides difficile 2021 Focused Update2021IQWiGIQWiG H20-04: Endoskopische Thermoablation der Duodenalschleimhaut bei Diabetes mellitus Typ 2 - Bewertung gemäß §137h SGB V2021IQWiGIQWiG H21-01: Endoskopische Thermoablation der Duodenalschleimhaut bei Diabetes mellitus Typ 2 - Addendum zum Auftrag H20-042021IQWiGIQWiG V19-03: Zusammenhang zwischen Leistungsmenge und Qualität des Behandlungsergebnisses bei komplexen Eingriffen am Organsystem Pankreas - Rapid Report2021USPSTFAspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: US Preventive Services Task Force Recommendation Statement.2021USPSTFBehavioral Counseling Interventions for Healthy Weight and Weight Gain in Pregnancy: US Preventive Services Task Force Recommendation Statement.2021USPSTFInterventions for Tobacco Smoking Cessation in Adults, Including Pregnant Persons: US Preventive Services Task Force Recommendation Statement.2021USPSTFScreening and Interventions to Prevent Dental Caries in Children Younger Than 5 Years: US Preventive Services Task Force Recommendation Statement.2021USPSTFScreening for Chlamydia and Gonorrhea: US Preventive Services Task Force Recommendation Statement.2021USPSTFScreening for Hearing Loss in Older Adults: US Preventive Services Task Force Recommendation Statement.2021USPSTFScreening for Hypertension in Adults: US Preventive Services Task Force Reaffirmation Recommendation Statement.2021USPSTFScreening for Lung Cancer: US Preventive Services Task Force Recommendation Statement.2021USPSTFScreening for Prediabetes and Type 2 Diabetes: US Preventive Services Task Force Recommendation Statement.2021USPSTFScreening for Vitamin D Deficiency in Adults: US Preventive Services Task Force Recommendation Statement.2021USPSTFUSPSTF Recommendation: Screening for Colorectal Cancer2021USPSTFUSPSTF: Colorectal Cancer: Screening (Grade A, 2021)2021WHOChecklists to Assess vulnerabilities in Health Care Facilities in the Context of Climate Change2021WHOFinancing common goods for health2021WHOQuality criteria for health national adaptation plans2021WHOUnderstanding barriers to quality of care: An approach for conducting a situational analysis of water, sanitation and hygiene (WASH) and quality in health care facilities2021WHOWHO Guideline on the prevention of drowning through provision of day-care and basic swimming and water safety skills2021WHOYouth-centred digital health interventions: a framework for planning, developing and implementing solutions with and for young people2021AkdÄAkdÄ: Information des PEI: Influenza-Impfstoff "Vaxigrip Tetra 2020/2021" aus Frankreich eingeführt.2020AkdÄAkdÄ: Rote-Hand-Brief zu Xeljanz® (Tofacitinib): Erhöhtes2020AkdÄAkdÄ: Umfrage des Paul-Ehrlich-Instituts zur Verfügbarkeit von Grippeimpfstoffen.2020AWMFHalsschmerzen2020CDCCDC Recommendations for Hepatitis C Screening Among Adults2020CochraneCochrane Review: Adalimumab for maintenance of remission in Crohn's disease2020CochraneCochrane Review: Anti-inflammatory medications for obstructive sleep apnoea in children2020CochraneCochrane Review: Antimicrobial mouthwashes (gargling) and nasal sprays to protect healthcare workers when undertaking aerosol-generating procedures2020CochraneCochrane Review: Aspirin and other non-steroidal anti-inflammatory drugs for the prevention of dementia2020CochraneCochrane Review: Band ligation versus sclerotherapy for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis2020CochraneCochrane Review: Barriers and facilitators to healthcare workers' adherence with infection prevention and control (IPC) guidelines for respiratory2020CochraneCochrane Review: Cognitive behavioural therapy for tinnitus2020CochraneCochrane Review: Colonoscopy-guided therapy for the prevention of post-operative recurrence of Crohn's disease2020CochraneCochrane Review: Conservative management of oesophageal soft food bolus impaction2020CochraneCochrane Review: Different infusion durations for preventing platinum-induced hearing loss in children with cancer2020CochraneCochrane Review: Digital contact tracing technologies in epidemics: a rapid review2020CochraneCochrane Review: Efficacy and safety of rapid tests to guide antibiotic prescriptions for sore throat2020CochraneCochrane Review: Exercise versus no exercise for the occurrence, severity, and duration of acute respiratory infections2020CochraneCochrane Review: Fibrin sealants for the prevention of postoperative pancreatic fistula following pancreatic surgery2020CochraneCochrane Review: Helicobacter pylori eradication for the prevention of gastric neoplasia2020CochraneCochrane Review: Interventions for fatigue in inflammatory bowel disease2020CochraneCochrane Review: Measures implemented in the school setting to contain the COVID-19 pandemic: a scoping review2020CochraneCochrane Review: Myofunctional therapy (oropharyngeal exercises) for obstructive sleep apnoea2020CochraneCochrane Review: N-acetylcysteine for non-paracetamol (acetaminophen)-related acute liver failure2020CochraneCochrane Review: Nasogastric versus nasojejunal tube feeding for severe acute pancreatitis2020CochraneCochrane Review: Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease2020CochraneCochrane Review: Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis2020CochraneCochrane Review: Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis2020CochraneCochrane Review: Pancreatic enzyme replacement therapy for people with cystic fibrosis2020CochraneCochrane Review: Personal protective equipment for preventing highly infectious diseases due to exposure to contaminated body fluids in healthcare staff2020CochraneCochrane Review: Physical activity interventions for disease-related physical and mental health during and following treatment in people with non-advanced colorectal cancer2020CochraneCochrane Review: Pioglitazone for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk for the development of type 2 diabetes mellitus2020CochraneCochrane Review: Portosystemic shunts versus endoscopic intervention with or without medical treatment for prevention of rebleeding in people with cirrhosis2020CochraneCochrane Review: Probiotics for induction of remission in Crohn's disease2020CochraneCochrane Review: Probiotics for induction of remission in ulcerative colitis2020CochraneCochrane Review: Probiotics for maintenance of remission in ulcerative colitis2020CochraneCochrane Review: Probiotics for people with cystic fibrosis2020CochraneCochrane Review: Proton pump inhibitors for chronic obstructive pulmonary disease2020CochraneCochrane Review: Quarantine alone or in combination with other public health measures to control COVID-19: a rapid review2020CochraneCochrane Review: Random drug and alcohol testing for preventing injury in workers2020CochraneCochrane Review: Reduction in saturated fat intake for cardiovascular disease2020CochraneCochrane Review: Rinse-free hand wash for reducing absenteeism among preschool and school children2020CochraneCochrane Review: Risk of postoperative infectious complications from medical therapies in inflammatory bowel disease2020CochraneCochrane Review: Salvage systemic therapy for advanced gastric and oesophago-gastric junction adenocarcinoma2020CochraneCochrane Review: Sclerotherapy versus beta-blockers for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis2020CochraneCochrane Review: Sclerotherapy versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis2020CochraneCochrane Review: Screening for type 2 diabetes mellitus2020CochraneCochrane Review: Screening strategies for hypertension2020CochraneCochrane Review: Surgery versus radical endotherapies for early cancer and high-grade dysplasia in Barrett's oesophagus2020CochraneCochrane Review: Targeted client communication via mobile devices for improving sexual and reproductive health2020CochraneCochrane Review: Tonsillectomy versus tonsillotomy for obstructive sleep-disordered breathing in children2020CochraneCochrane Review: Treatment for ascites in adults with decompensated liver cirrhosis: a network meta-analysis2020CochraneCochrane Review: Use of antimicrobial mouthwashes (gargling) and nasal sprays by healthcare workers to protect them when treating patients with suspected or confirmed COVID-19 infection2020CochraneCochrane Review: Workplace pedometer interventions for increasing physical activity2020DGVSDGVS: Hepatitis C2020G-BAG-BA Nutzenbewertung: Avapritinib (Gastrointestinale Stromatumoren)2020G-BAG-BA Nutzenbewertung: Encorafenib (Neues Anwendungsgebiet: metastasiertes Kolorektalkarzinom (CRC) mit BRAF-V600E-Mutation nach systemischer Vortherapie)2020G-BAG-BA Nutzenbewertung: Naldemedin (Opioid-induzierte Obstipation)2020G-BAG-BA Nutzenbewertung: Olaparib (Neues Anwendungsgebiet: Adenokarzinom des Pankreas, BRCA1/2-Mutationen, Erhaltungstherapie)2020G-BAG-BA Nutzenbewertung: Trifluridin/Tipiracil (Neubewertung nach Fristablauf: Kolorektalkarzinom, vorbehandelte Patienten)2020IQWiGIQWiG A19-43: Wissenschaftliche Ausarbeitung von Konzepten zur Generierung versorgungsnaher Daten und deren Auswertung zum Zwecke der Nutzenbewertung von Arzneimitteln nach § 35a SGB V - Rapid Report2020IQWiGIQWiG A20-45: Naldemedin (Opioid-induzierte Obstipation) - Nutzenbewertung gemäß §35a SGB V2020IQWiGIQWiG G20-23: Naldemedin (opioidinduzierte Obstipation) - Addendum zum Auftrag A20-452020USPSTFBehavioral Counseling Interventions to Prevent Sexually Transmitted Infections: US Preventive Services Task Force Recommendation Statement.2020USPSTFPrimary Care Interventions for Prevention and Cessation of Tobacco Use in Children and Adolescents: US Preventive Services Task Force Recommendation Statement.2020USPSTFPrimary Care-Based Interventions to Prevent Illicit Drug Use in Children, Adolescents, and Young Adults: US Preventive Services Task Force Recommendation Statement.2020USPSTFScreening for Bacterial Vaginosis in Pregnant Persons to Prevent Preterm Delivery: US Preventive Services Task Force Recommendation Statement.2020USPSTFScreening for Cognitive Impairment in Older Adults: US Preventive Services Task Force Recommendation Statement.2020USPSTFScreening for Hepatitis B Virus Infection in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement.2020USPSTFScreening for Hepatitis C Virus Infection in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement.2020USPSTFScreening for High Blood Pressure in Children and Adolescents: US Preventive Services Task Force Recommendation Statement.2020USPSTFScreening for Unhealthy Drug Use: US Preventive Services Task Force Recommendation Statement.2020USPSTFUSPSTF: Hepatitis B Virus Infection: Screening (Grade B, 2020)2020USPSTFUSPSTF: Hepatitis C Virus Infection: Screening (Grade B, 2020)2020WHOCore competencies for infection prevention and control professionals2020WHODetoxifying agriculture and health from highly hazardous pesticides -- A call for action2020WHOExploration of COVID-19 health-care worker cases : implications for action2020WHOGuidance for research ethics committees for rapid review of research during public health emergencies2020WHOGuidance on mainstreaming biodiversity for nutrition and health2020WHOInternational health regulations (2005): assessment tool for core capacity requirements at designated airports, ports and ground crossings2020WHOIntroducing and scaling up testing for human papillomavirus as part of a comprehensive programme for prevention and control of cervical cancer2020WHOMonitoring and evaluation framework2020WHOPrevention, identification and management of health worker infection in the context of COVID-192020WHOScreening programmes: a short guide. Increase effectiveness, maximize benefits and minimize harm2020WHOWHO technical guidance and specifications of medical devices for screening and treatment of precancerous lesions in the prevention of cervical cancer2020AkdÄAkdÄ Bekanntgabe: Rezidiv eines Morbus Crohn nach Behandlung einer atopischen Dermatitis mit Dupilumab2019ATSRadiation Pneumonitis and Fibrosis: An Official American Thoracic Society Clinical Practice Guideline2019BfArMRanitidin: Rückruf von ranitidinhaltigen Arzneimitteln2019CochraneCochrane Review: Abdominal ultrasound for diagnosing abdominal tuberculosis or disseminated tuberculosis with abdominal involvement in HIV-positive individuals2019CochraneCochrane Review: Acetyl-L-carnitine for patients with hepatic encephalopathy2019CochraneCochrane Review: Acupuncture for chronic hepatitis B2019CochraneCochrane Review: Adalimumab for induction of remission in Crohn's disease2019CochraneCochrane Review: Additional behavioural support as an adjunct to pharmacotherapy for smoking cessation2019CochraneCochrane Review: Adjuvant therapy with antidepressants for the management of inflammatory bowel disease2019CochraneCochrane Review: Anti-IL-12/23p40 antibodies for maintenance of remission in Crohn's disease2019CochraneCochrane Review: Antiamoebic drugs for treating amoebic colitis2019CochraneCochrane Review: Antibiotics for induction and maintenance of remission in Crohn's disease2019CochraneCochrane Review: Antiviral treatment for Bell's palsy (idiopathic facial paralysis)2019CochraneCochrane Review: Azathioprine and 6-mercaptopurine for maintenance of surgically-induced remission in Crohn's disease2019CochraneCochrane Review: Band ligation versus beta-blockers for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis2019CochraneCochrane Review: Band ligation versus no intervention for primary prevention of upper gastrointestinal bleeding in adults with cirrhosis and oesophageal varices2019CochraneCochrane Review: Biofeedback for treatment of irritable bowel syndrome2019CochraneCochrane Review: Certolizumab pegol for induction of remission in Crohn's disease2019CochraneCochrane Review: Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV-related disease in females and males2019CochraneCochrane Review: Dietary interventions for induction and maintenance of remission in inflammatory bowel disease2019CochraneCochrane Review: Exercise interventions for smoking cessation2019CochraneCochrane Review: Follow-up strategies for patients treated for non-metastatic colorectal cancer2019CochraneCochrane Review: Fortification of wheat and maize flour with folic acid for population health outcomes2019CochraneCochrane Review: Glucocorticosteroids for people with alcoholic hepatitis2019CochraneCochrane Review: Human resource management training of supervisors for improving health and well-being of employees2019CochraneCochrane Review: Interventions for maintenance of surgically induced remission in Crohn's disease: a network meta-analysis2019CochraneCochrane Review: Interventions for preventing osteoradionecrosis of the jaws in adults receiving head and neck radiotherapy2019CochraneCochrane Review: Interventions to increase adherence to medications for tobacco dependence2019CochraneCochrane Review: Intranasal corticosteroids for non-allergic rhinitis2019CochraneCochrane Review: Intraoperative neuromonitoring versus visual nerve identification for prevention of recurrent laryngeal nerve injury in adults undergoing thyroid surgery2019CochraneCochrane Review: Lipid emulsions for parenterally fed term and late preterm infants2019CochraneCochrane Review: Medical interventions for the prevention of platinum-induced hearing loss in children with cancer2019CochraneCochrane Review: Mediterranean-style diet for the primary and secondary prevention of cardiovascular disease2019CochraneCochrane Review: Metformin for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus2019CochraneCochrane Review: Oral 5-aminosalicylic acid for maintenance of surgically-induced remission in Crohn's disease2019CochraneCochrane Review: Pharmacological interventions for prevention and treatment of upper gastrointestinal bleeding in newborn infants2019CochraneCochrane Review: Pharmacotherapies that specifically target ammonia for the prevention and treatment of hepatic encephalopathy in adults with cirrhosis2019CochraneCochrane Review: Plasma expanders for people with cirrhosis and large ascites treated with abdominal paracentesis2019CochraneCochrane Review: Positional therapy for obstructive sleep apnoea2019CochraneCochrane Review: Smoking reduction interventions for smoking cessation2019CochraneCochrane Review: Speech and language therapy for management of chronic cough2019CochraneCochrane Review: Stopping enteral feeds for prevention of transfusion-associated necrotising enterocolitis in preterm infants2019CochraneCochrane Review: Tonsillectomy for periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis syndrome (PFAPA)2019CochraneCochrane Review: Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis2019G-BAG-BA Nutzenbewertung: Dupilumab (neues Anwendungsgebiet: Chronische Rhinosinusitis mit Nasenpolypen)2019G-BAG-BA Nutzenbewertung: Pembrolizumab (neues Anwendungsgebiet: Plattenepithelkarzinom Kopf-Hals-Bereich, PD-L1-Expression ≥ 1%, Erstlinie, Kombination2019G-BAG-BA Nutzenbewertung: Trifluridin/Tipiracil (neues Anwendungsgebiet: metastasiertes Magenkarzinom, vorbehandelte Patienten)2019IQWiGIQWiG GA16-02: Kommunikation von Unsicherheit in Gesundheitsinformationen2019Leitlinienprogramm OnkologieS3-Leitlinie Kolorektales Karzinom (2019)2019RKIRKI-Ratgeber: Campylobacter-Enteritis2019RKIRKI-Ratgeber: Norovirus-Gastroenteritis2019RKIRKI-Ratgeber: Rotaviren-Gastroenteritis2019RKIRKI-Ratgeber: Salmonellose2019RKIRKI-Ratgeber: Yersiniose2019USPSTFInterventions to Prevent Perinatal Depression: US Preventive Services Task Force Recommendation Statement.2019USPSTFMedication Use to Reduce Risk of Breast Cancer: US Preventive Services Task Force Recommendation Statement.2019USPSTFOcular Prophylaxis for Gonococcal Ophthalmia Neonatorum: US Preventive Services Task Force Reaffirmation Recommendation Statement.2019USPSTFPreexposure Prophylaxis for the Prevention of HIV Infection: US Preventive Services Task Force Recommendation Statement.2019USPSTFRisk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.2019USPSTFScreening for Abdominal Aortic Aneurysm: US Preventive Services Task Force Recommendation Statement.2019USPSTFScreening for Asymptomatic Bacteriuria in Adults: US Preventive Services Task Force Recommendation Statement.2019USPSTFScreening for Hepatitis B Virus Infection in Pregnant Women: US Preventive Services Task Force Reaffirmation Recommendation Statement.2019USPSTFScreening for HIV Infection: US Preventive Services Task Force Recommendation Statement.2019USPSTFScreening for Pancreatic Cancer: US Preventive Services Task Force Reaffirmation Recommendation Statement.2019WHOEar and hearing care: indicators for monitoring provision of services2019WHOGlobal Influenza Strategy 2019–20302019WHOHealthcare without avoidable infections2019WHOSouth East Asia Tobacco Industry Interference Index2019WHOTechnical series on adapting to climate sensitive health impacts: undernutrition2019WHOWASH in health care facilities: Practical steps to achieve universal access to quality care2019ACGACG Clinical Guideline: Management of Crohn's Disease in Adults2018AkdÄAkdÄ Bekanntgabe: Induktion und/oder Demaskierung von chronisch-entzündlichen Darmerkrankungen unter Secukinumab2018AkdÄAkdÄ: „Aus der UAW-Datenbank“: Induktion und/oder2018AkdÄAkdÄ: Informationsbrief zu Iberogast®: Textergänzungen in der Fach- und Gebrauchsinformation.2018AkdÄAkdÄ: Informationsschreiben zu undichten Spritzen bei einigen Impfstoffen.2018DGVSDGVS: Neuroendokrine Tumore2018Diabetes CanadaDiabetes Canada Chapter 5: Reducing the Risk of Developing Diabetes2018G-BAG-BA Nutzenbewertung: Darvadstrocel (Anale Fisteln bei Morbus Crohn)2018G-BAG-BA Nutzenbewertung: Pembrolizumab (neues Anwendungsgebiet: Plattenepithelkarzinom Kopf-Hals-Bereich)2018G-BAG-BA Nutzenbewertung: Tofacitinib (neues Anwendungsgebiet: Colitis Ulcerosa)2018IQWiGIQWiG G17-13: Telotristatethyl (Karzinoid-Syndrom-bedingte Diarrhö) - Bewertung gemäß § 35a Abs. 1 Satz 11 SGB V2018IQWiGIQWiG H18-01: Sonografiegesteuerte hochfokussierte Ultraschalltherapie bei bösartigen Neubildungen des Pankreas – 2. Addendum zum Auftrag H16-02C2018IQWiGIQWiG S16-03: Screening auf Hepatitis B2018IQWiGIQWiG S17-01: Darmkrebsfrüherkennung bei Personen mit familiärem Risiko - Aktualisierung zum Auftrag S11-012018USPSTFBehavioral Counseling to Prevent Skin Cancer: US Preventive Services Task Force Recommendation Statement.2018USPSTFBehavioral Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults: US Preventive Services Task Force Recommendation Statement.2018USPSTFScreening and Behavioral Counseling Interventions to Reduce Unhealthy Alcohol Use in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement.2018USPSTFScreening for Adolescent Idiopathic Scoliosis: US Preventive Services Task Force Recommendation Statement.2018USPSTFScreening for Atrial Fibrillation With Electrocardiography: US Preventive Services Task Force Recommendation Statement.2018USPSTFScreening for Cardiovascular Disease Risk With Electrocardiography: US Preventive Services Task Force Recommendation Statement.2018USPSTFScreening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement.2018USPSTFScreening for Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: US Preventive Services Task Force Final Recommendation Statement.2018USPSTFScreening for Ovarian Cancer: US Preventive Services Task Force Recommendation Statement.2018USPSTFScreening for Peripheral Artery Disease and Cardiovascular Disease Risk Assessment With the Ankle-Brachial Index: US Preventive Services Task Force Recommendation Statement.2018USPSTFScreening for Syphilis Infection in Pregnant Women: US Preventive Services Task Force Reaffirmation Recommendation Statement.2018WHOGeneric risk assessment model for indoor and outdoor space spraying of insecticides — Second Edition2018WHOWHO Housing and health guidelines2018ACGACG: H. pylori Infection Management2017AkdÄAkdÄ: Direkt wirkende antivirale Arzneimittel (DAA): EMA bestätigt die Empfehlung zum Hepatitis-B-Screening.2017AkdÄAkdÄ: Information des BfArM zu Symbioflor® 2 (Escherichia2017G-BAG-BA Nutzenbewertung: Nivolumab (neues Anwendungsgebiet: Plattenepithelkarzinom Kopf-Hals-Bereich)2017G-BAG-BA Nutzenbewertung: Obeticholsäure2017IQWiGIQWiG G16-10: Teduglutid (Kurzdarmsyndrom, Patienten ab dem Alter von 1 Jahr) - Bewertung gemäß § 35a Abs. 1 Satz 10 SGB V2017IQWiGIQWiG H17-03: Sonografiegesteuerte hochfokussierte Ultraschalltherapie bei bösartigen Neubildungen des Pankreas - Addendum zum Auftrag H16-02C2017SIGNSIGN 149: Risk Estimation and the Prevention of Cardiovascular Disease2017USPSTFBehavioral Counseling to Promote a Healthful Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Risk2017USPSTFFolic Acid Supplementation for the Prevention of Neural Tube Defects: US Preventive Services Task Force Recommendation Statement.2017USPSTFScreening for Celiac Disease: US Preventive Services Task Force Recommendation Statement.2017USPSTFScreening for Gynecologic Conditions With Pelvic Examination: US Preventive Services Task Force Recommendation Statement.2017USPSTFScreening for Obesity in Children and Adolescents: US Preventive Services Task Force Recommendation Statement.2017USPSTFScreening for Preeclampsia: US Preventive Services Task Force Recommendation Statement.2017USPSTFScreening for Thyroid Cancer: US Preventive Services Task Force Recommendation Statement.2017USPSTFVision Screening in Children Aged 6 Months to 5 Years: US Preventive Services Task Force Recommendation Statement.2017AkdÄAkdÄ Bekanntgabe: Fulminante Myokarditis mit akuter kardialer Dekompensation nach Erstgabe von Adalimumab (Humira®) bei Colitis ulcerosa2016G-BAG-BA Nutzenbewertung: Ramucirumab (neues Anwendungsgebiet: Kolorektalkarzinom)2016G-BAG-BA Nutzenbewertung: Teduglutid (neues Anwendungsgebiet: Kurzdarmsyndrom, 1 bis < 18 Jahre)2016G-BAG-BA Nutzenbewertung: Trifluridin/Tipiracil (Kolorektalkarzinom, vorbehandelte Patienten)2016IQWiGIQWiG P14-03: Einladungsschreiben und Entscheidungshilfe zum Mammographie-Screening2016USPSTFSerologic Screening for Genital Herpes Infection: US Preventive Services Task Force Recommendation Statement.2016G-BAG-BA Nutzenbewertung: Gaxilose2015G-BAG-BA Nutzenbewertung: Regorafenib (neues Anwendungsgebiet: Gastrointestinale Stromatumore)2014G-BAG-BA Nutzenbewertung: Teduglutid (Kurzdarmsyndrom)2014G-BAG-BA Nutzenbewertung: Vedolizumab (Colitis ulcersosa, Morbus Crohn)2014IQWiGIQWiG A14-23: Vedolizumab - Nutzenbewertung gemäß § 35a SGB V (Dossierbewertung)2014IQWiGIQWiG G14-03: Cholsäure - Bewertung gemäß § 35a Abs. 1 Satz 10 SGB V (Dossierbewertung)2014IQWiGIQWiG G14-10: Teduglutid - Bewertung gemäß § 35a Abs. 1 Satz 10 SGB V (Dossierbewertung)2014AkdÄAkdÄ Bekanntgabe: Sprue-ähnliche Enteropathie unter Olmesartan2013G-BAG-BA Nutzenbewertung: Aflibercept (neues Anwendungsgebiet: Kolorektalkarzinom)2013G-BAG-BA Nutzenbewertung: Linaclotid (Reizdarmsyndrom mit Obstipation)2013IQWiGIQWiG A13-05: Fidaxomicin - Nutzenbewertung gemäß § 35a SGB V (Dossierbewertung)2013IQWiGIQWiG A13-21: Linaclotid - Nutzenbewertung gemäß § 35a SGB V (Dossierbewertung)2013IQWiGIQWiG S11-01: Bewertung des Nutzens einer Früherkennungsuntersuchung für Personen unter 55 Jahren mit familiärem Darmkrebsrisiko2013WHOGuidelines for the safe use of wastewater, excreta and greywater - Volume 12013AkdÄAkdÄ Bekanntgabe: Isotretinoin und chronisch-entzündliche Darmerkrankung2012G-BAG-BA Nutzenbewertung: Tegafur/Gimeracil/Oteracil (Magenkarzinom)2012IQWiGIQWiG P10-01: Primärprävention und Gesundheitsförderung bei Männern - Rapid Report2012WHOGlobal Strategy for dengue prevention and control, 2012–20202012WHOGuideline: potassium intake for adults and children2012WHOGuideline: sodium intake for adults and children2012WHOJoint request for selected preventive chemotherapy medicines and joint reporting form: a user guide2012WHOInterim planning considerations for mass gatherings in the context of pandemic (H1N1) 2009 influenza2011WHOReducing transmission of pandemic (H1N1) 2009 in school settings2009IQWiGIQWiG S05-01: Früherkennungsuntersuchung von Hörstörungen bei Neugeborenen2008IQWiGIQWiG G05-01A: Entwicklung und Erstellung eines Prognosemodells zur Ermittlung der Auswirkungen von Schwellenwerten auf die Versorgung2006IQWiGIQWiG GA05-02: R-COD-Browser - Webbasierte Software zur Ermittlung von Mortalitätsraten in Deutschland für beliebige Todesursachen nach ICD-10 im Zeitraum 1998-20032006IQWiGIQWiG GA05-06: ebm@school - Entwicklung eines Curriculums zur Vermittlung grundlegender Kompetenzen für den Umgang mit medizinischen Fragen bei Schülern2006IQWiGIQWiG P04-01: Konzept zur Erstellung von Patienteninformationen des IQWiG2005BfArMMeloxicam: Nebenwirkungen an der Haut und am Gastrointestinaltrakt1998
Und über 2.500 weitere Leitlinien aus AWMF, NVL, RKI, WHO, NICE u.a.
Häufige Fragen
ClariMed enthält DGHNO-Leitlinien zu Rhinosinusitis, Hörsturz, Tonsillitis, Otitis media und weitere HNO-relevante AWMF-Leitlinien.
Weitere Fachgebiete
Leitlinien-Suche starten
Durchsuchen Sie HNO-Heilkunde-Leitlinien und weitere Quellen — kostenlos und ohne Anmeldung.
Jetzt suchenStand: 5. September 2026